ATE233898T1 - Verfahren zur aktivierung von blutgerinnungsfaktor xii - Google Patents

Verfahren zur aktivierung von blutgerinnungsfaktor xii

Info

Publication number
ATE233898T1
ATE233898T1 AT97115720T AT97115720T ATE233898T1 AT E233898 T1 ATE233898 T1 AT E233898T1 AT 97115720 T AT97115720 T AT 97115720T AT 97115720 T AT97115720 T AT 97115720T AT E233898 T1 ATE233898 T1 AT E233898T1
Authority
AT
Austria
Prior art keywords
factor xii
blood clotting
clotting factor
activating blood
receptor
Prior art date
Application number
AT97115720T
Other languages
English (en)
Inventor
Yoji Shibayama
Kinashi
Allen P Kaplan
Original Assignee
Nippon Zoki Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Zoki Pharmaceutical Co filed Critical Nippon Zoki Pharmaceutical Co
Application granted granted Critical
Publication of ATE233898T1 publication Critical patent/ATE233898T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96433—Serine endopeptidases (3.4.21)
    • G01N2333/96441—Serine endopeptidases (3.4.21) with definite EC number
    • G01N2333/96458—Factor XII (3.4.21.38)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Ceramic Products (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
AT97115720T 1996-09-12 1997-09-10 Verfahren zur aktivierung von blutgerinnungsfaktor xii ATE233898T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP8265318A JPH1084995A (ja) 1996-09-12 1996-09-12 血液凝固第ｘｉｉ因子活性化法

Publications (1)

Publication Number Publication Date
ATE233898T1 true ATE233898T1 (de) 2003-03-15

Family

ID=17415534

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97115720T ATE233898T1 (de) 1996-09-12 1997-09-10 Verfahren zur aktivierung von blutgerinnungsfaktor xii

Country Status (8)

Country Link
US (1) US6117648A (de)
EP (1) EP0829725B1 (de)
JP (1) JPH1084995A (de)
KR (1) KR100497951B1 (de)
CN (1) CN1138002C (de)
AT (1) ATE233898T1 (de)
DE (1) DE69719425T2 (de)
TW (1) TW521089B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6913900B2 (en) * 2001-08-29 2005-07-05 Nippon Zoki Pharmaceutical Co., Ltd. Plasma prekallikrein activation and kallikrein production assay
EP4234583A3 (de) 2013-01-20 2024-01-24 Takeda Pharmaceutical Company Limited Untersuchung und behandlung von bradykininvermittelten erkrankungen
CA2927695C (en) 2013-10-21 2022-03-01 Dyax Corp. Diagnosis and treatment of autoimmune diseases
WO2015061183A1 (en) 2013-10-21 2015-04-30 Dyax Corp. Assays for determining plasma kallikrein system biomarkers
EP4354146B1 (de) * 2015-10-19 2026-04-15 Takeda Pharmaceutical Company Limited Immunoassay zum nachweis von gespaltenem kininogen mit hohem molekulargewicht

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63185398A (ja) * 1986-09-10 1988-07-30 Nippon Zoki Pharmaceut Co Ltd 生理活性物質測定法
JPH0414000A (ja) * 1990-05-07 1992-01-17 Fujitsu Ltd 放射線装置
JP3213831B2 (ja) * 1993-08-06 2001-10-02 日本臓器製薬株式会社 被検物質の活性測定方法
JP3213832B2 (ja) * 1993-08-06 2001-10-02 日本臓器製薬株式会社 被検物質の活性測定法
JP2594222B2 (ja) * 1993-09-28 1997-03-26 日本臓器製薬株式会社 新規生理活性物質−ｋｆ

Also Published As

Publication number Publication date
CN1182137A (zh) 1998-05-20
DE69719425D1 (de) 2003-04-10
KR100497951B1 (ko) 2005-09-30
TW521089B (en) 2003-02-21
EP0829725A3 (de) 1998-06-10
DE69719425T2 (de) 2003-12-18
EP0829725B1 (de) 2003-03-05
JPH1084995A (ja) 1998-04-07
KR19980024488A (ko) 1998-07-06
CN1138002C (zh) 2004-02-11
US6117648A (en) 2000-09-12
EP0829725A2 (de) 1998-03-18

Similar Documents

Publication Publication Date Title
DE3786641D1 (de) Einheit zur aufnahme von blutbestandteilen.
DE3788353D1 (de) Vorrichtung und verfahren zur musternahme von arteriellem und venösem blut.
ES2064439T3 (es) Material adhesivo quirurgico.
DE69005959D1 (de) Verfahren zur Reinigung von menschlichem Serum-Albumin.
ATE233898T1 (de) Verfahren zur aktivierung von blutgerinnungsfaktor xii
ATE72337T1 (de) Immunochemisches verfahren zur bestimmung von stabilem glykosiliertem haemoglobin.
DE68918083D1 (de) Verfahren zur reinigung von blutplasma.
DE69016879D1 (de) Verfahren zur Reinigung von N-Phosphonmethylglyzin.
ATE174624T1 (de) Verfahren zur aktivierung von blutgerinnungsfaktoren
DE69433875D1 (de) Verfahren zur präparation von humanem aktiviertem protein c
DE68924646D1 (de) Verfahren zur herstellung von zinkoxid-whiskern.
DE59309127D1 (de) Verfahren zur Reaktivierung von gereinigten Membranproteinen
DE68910771D1 (de) Verfahren zur Herstellung von verbessertem Proteinhydrolysat.
ATE260336T1 (de) Verfahren zur aktivierung von prothrombin zu thrombin
DE69019810D1 (de) Verfahren zur optischen Bestimmung von Bilirubin und Reagenz dafür.
DE69005609D1 (de) Verfahren zur Herstellung von Alkan- und Arensulfonamiden.
DE68910871D1 (de) Verfahren zur Herstellung von Cumol.
DE58906820D1 (de) Verfahren zur Herstellung von Aralkylhydroperoxiden.
DE59004279D1 (de) Verfahren zur C-terminalen Modifizierung von Proteinen.
DE3679763D1 (de) Verfahren und zusammensetzungen zur bestimmung von heparin.
DE3761760D1 (de) Verfahren zur aufbereitung von cyclohexylhydroperoxid enthaltenden reaktionsgemischen.
DK0570355T3 (da) Anvendelse af prothrombin-fragmenter
DE69316293D1 (de) Methode zur Bestimmung von Fibrinogen, trockenes Reagens hierfür und Verfahren zur Herstellung desselben
ATE106893T1 (de) Verfahren zur herstellung von aktiviertem protein c.
ATE78598T1 (de) Immunassay unter benutzung der mikropartikelneutralisierung.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties